NCT02241161

Brief Summary

Aim of the study was to evaluate the soothing and re-epithelizing activity of a single application of topical products on experimentally induced erythema by skin stripping on the forearm (volar surface) of 20 healthy volunteers. In particular the activity of the following three cosmetic products and the relative combinations (cream and serum) were assessed: rejuvenating cream, rejuvenating serum, antioxidant serum

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for phase_3 healthy

Timeline
Completed

Started Dec 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 18, 2014

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 16, 2014

Completed
Last Updated

September 16, 2014

Status Verified

March 1, 2014

Enrollment Period

Same day

First QC Date

July 18, 2014

Last Update Submit

September 12, 2014

Conditions

Keywords

skin eythemarejuvenating creamrejuvenating serumantioxidant serum

Outcome Measures

Primary Outcomes (1)

  • Clinical evaluation of skin erythema: change from baseline, 1 hour after products application (T1h vs. T0)

    Skin erythema was scored and recorded according to the following grades: 0=no erythema; 0.5=very slight erythema (barely perceptible);1=well-defined erythema;1.5=moderate to severe erythema; 2=severe erythema (beet redness) to slight eschar formation (injuries in depth)

    After 1 (T1h) hour from products application

Secondary Outcomes (8)

  • Clinical evaluation of skin erythema: change from baseline, 6 hours from products application (T6h vs. T0)

    After 6 (T6h) hours from products application

  • Clinical evaluation of skin erythema: change from baseline, after 24 hours from products application (T24h vs. T0)

    After 24 (T24h) hours from products application

  • Optical densitometry: change from baseline, after 1hour from products application (T1h vs. T0)

    After 1 (T1h) hour from products application

  • Optical densitometry: change from baseline, 6 hours from products application (T6h vs. T0)

    After 6 (T6h) hours from products application

  • Optical densitometry: change from baseline, 24 hours from products application (T24h vs.T0)

    After 24 (T24h) hours from products application

  • +3 more secondary outcomes

Study Arms (5)

plantaricin a - rejuvenating cream

ACTIVE COMPARATOR

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

Other: plantaricin a - rejuvenating cream

plantaricin a - rejuvenating serum

ACTIVE COMPARATOR

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

Other: plantaricin a - rejuvenating serum

plantaricin a - antioxidant serum

ACTIVE COMPARATOR

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

Other: plantaricin a - antioxidant serum

plantaricin a (rejuvenating cream +rejuvenating serum)

ACTIVE COMPARATOR

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

Other: plantaricin a - rejuvenating creamOther: plantaricin a - rejuvenating serum

plantaricin a (rejuvenating cream + antioxidant serum)

ACTIVE COMPARATOR

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

Other: plantaricin a - rejuvenating creamOther: plantaricin a - antioxidant serum

Interventions

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

plantaricin a (rejuvenating cream + antioxidant serum)plantaricin a (rejuvenating cream +rejuvenating serum)plantaricin a - rejuvenating cream

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

plantaricin a (rejuvenating cream + antioxidant serum)plantaricin a - antioxidant serum

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

plantaricin a (rejuvenating cream +rejuvenating serum)plantaricin a - rejuvenating serum

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult volunteers of both sexes, aged more than 18 years old
  • Volunteers in a good general state of health in the Investigator opinion
  • Volunteers not taking drugs or undergoing surgical procedure
  • Volunteers who are giving a written informed consent.

You may not qualify if:

  • Pregnancy (only for female subjects)
  • lactation (only for female subjects)
  • change in the normal habits in the last month
  • participation in a similar study during the previous month
  • known allergy to one or several ingredients of the products on trial
  • insufficient adhesion to the study protocol
  • dermatological disease
  • clinical and significant skin condition on the test area (e.g. lesions, scars, malformations)
  • diabetes
  • endocrine disease
  • hepatic, renal or cardiac disorder
  • cancer
  • topical drugs or surgical procedure on the test areas during the previous 3 months
  • systemic corticosteroids
  • aspirin or non-steroid anti-inflammatory drugs (FANS)
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

DermIng SRL

Monza, Monza, 20900, Italy

Location

Related Publications (21)

  • Buonocore D, Lazzeretti A, Tocabens P, Nobile V, Cestone E, Santin G, Bottone MG, Marzatico F. Resveratrol-procyanidin blend: nutraceutical and antiaging efficacy evaluated in a placebocontrolled, double-blind study. Clin Cosmet Investig Dermatol. 2012;5:159-65. doi: 10.2147/CCID.S36102. Epub 2012 Oct 5.

    PMID: 23071399BACKGROUND
  • Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996 Jul 15;239(1):70-6. doi: 10.1006/abio.1996.0292.

    PMID: 8660627BACKGROUND
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248-54. doi: 10.1016/0003-2697(76)90527-3. No abstract available.

    PMID: 942051BACKGROUND
  • Calcabrini C, De Bellis R, Mancini U, Cucchiarini L, Potenza L, De Sanctis R, Patrone V, Scesa C, Dacha M. Rhodiola rosea ability to enrich cellular antioxidant defences of cultured human keratinocytes. Arch Dermatol Res. 2010 Apr;302(3):191-200. doi: 10.1007/s00403-009-0985-z. Epub 2009 Aug 25.

    PMID: 19705137BACKGROUND
  • Corcuff P, Chatenay F, Leveque JL. A fully automated system to study skin surface patterns. Int J Cosmet Sci. 1984 Aug;6(4):167-76. doi: 10.1111/j.1467-2494.1984.tb00373.x.

    PMID: 19467109BACKGROUND
  • De Jongh CM, Verberk MM, Withagen CE, Jacobs JJ, Rustemeyer T, Kezic S. Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate. Contact Dermatitis. 2006 Jun;54(6):325-33. doi: 10.1111/j.0105-1873.2006.00848.x.

    PMID: 16787454BACKGROUND
  • Int J Cosm Sci 6: 167-186, 1984 Fernay, Voltaire The World Medical Association (1989)

    BACKGROUND
  • Elsner P, Barel AO, Berardesca E, Gapard B, Serup J Skin Bioengineering Techniques and Applications in Dermatology and Cosmetology Karger, 1998

    BACKGROUND
  • Fuga GC, Spina C, Cavallotti C, Di Palma A, Lombardi G, Marmo W Computerized reflected optical densitometry. A research on the colour of the skin. Journal of Applied Cosmetology, 8:91-110,1990

    BACKGROUND
  • Fullerton A, Fischer T, Lahti A, Wilhelm KP, Takiwaki H, Serup J. Guidelines for measurement of skin colour and erythema. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis. 1996 Jul;35(1):1-10. doi: 10.1111/j.1600-0536.1996.tb02258.x.

    PMID: 8896947BACKGROUND
  • Garcia Ortiz P, Hansen SH, Shah VP, Menne T, Benfeldt E. Impact of adult atopic dermatitis on topical drug penetration: assessment by cutaneous microdialysis and tape stripping. Acta Derm Venereol. 2009;89(1):33-8. doi: 10.2340/00015555-0562.

    PMID: 19197539BACKGROUND
  • Grove GL, Zerweck CR, Houser TP, Smith GE, Koski NI. A randomized and controlled comparison of gentleness of 2 medical adhesive tapes in healthy human subjects. J Wound Ostomy Continence Nurs. 2013 Jan-Feb;40(1):51-9. doi: 10.1097/WON.0b013e318276f2a4.

    PMID: 23202590BACKGROUND
  • ICH Harmonised Tripartite Guideline - Guideline for Good Clinical Practice International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: May 1996

    BACKGROUND
  • Lademann J, Meinke MC, Schanzer S, Richter H, Darvin ME, Haag SF, Fluhr JW, Weigmann HJ, Sterry W, Patzelt A. In vivo methods for the analysis of the penetration of topically applied substances in and through the skin barrier. Int J Cosmet Sci. 2012 Dec;34(6):551-9. doi: 10.1111/j.1468-2494.2012.00750.x. Epub 2012 Sep 25.

    PMID: 22957937BACKGROUND
  • Lademann J, Jacobi U, Surber C, Weigmann HJ, Fluhr JW. The tape stripping procedure--evaluation of some critical parameters. Eur J Pharm Biopharm. 2009 Jun;72(2):317-23. doi: 10.1016/j.ejpb.2008.08.008. Epub 2008 Aug 19.

    PMID: 18775778BACKGROUND
  • Lindemann U, Wilken K, Weigmann HJ, Schaefer H, Sterry W, Lademann J. Quantification of the horny layer using tape stripping and microscopic techniques. J Biomed Opt. 2003 Oct;8(4):601-7. doi: 10.1117/1.1609200.

    PMID: 14563197BACKGROUND
  • Marttin E, Neelissen-Subnel MT, De Haan FH, Bodde HE. A critical comparison of methods to quantify stratum corneum removed by tape stripping. Skin Pharmacol. 1996;9(1):69-77. doi: 10.1159/000211392.

    PMID: 8868035BACKGROUND
  • Sachs L Applied statistics: a handbook of techniques. Heidelberg: Springer, 1981:536-539

    BACKGROUND
  • Serup J, Agner T. Colorimetric quantification of erythema--a comparison of two colorimeters (Lange Micro Color and Minolta Chroma Meter CR-200) with a clinical scoring scheme and laser-Doppler flowmetry. Clin Exp Dermatol. 1990 Jul;15(4):267-72. doi: 10.1111/j.1365-2230.1990.tb02087.x.

    PMID: 2208776BACKGROUND
  • Takiwaki H. Measurement of skin color: practical application and theoretical considerations. J Med Invest. 1998 Feb;44(3-4):121-6.

    PMID: 9597799BACKGROUND
  • Weigmann H, Lademann J, Meffert H, Schaefer H, Sterry W. Determination of the horny layer profile by tape stripping in combination with optical spectroscopy in the visible range as a prerequisite to quantify percutaneous absorption. Skin Pharmacol Appl Skin Physiol. 1999 Jan-Apr;12(1-2):34-45. doi: 10.1159/000029844.

    PMID: 10325582BACKGROUND

Related Links

Study Officials

  • Adele Sparavigna, Doctor

    Derming SRL

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2014

First Posted

September 16, 2014

Study Start

December 1, 2013

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

September 16, 2014

Record last verified: 2014-03

Locations